miRNA-21 Serum Evaluation in BPH, Hormone Sensitive Prostate Cancer, and Castrate Resistant Prostate Cancer: Attempt for Diagnostic Biomarker Evaluation

BACKGROUND: Some of prostate cancer cases could progress to be Castrate Resistant Prostate Cancer (CRPC). However it is still a challenge to early diagnose it since no reliable examination could be done except PSA, which has high variability. It is now known that miRNAs are involved in nearly all in...

Descripción completa

Detalles Bibliográficos
Autores principales: Seputra, Kurnia Penta, Purnomo, Basuki Bambang, Susianti, Hani, Kalim, Handono, Purnomo, Athaya Febriantyo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical sciences 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800573/
https://www.ncbi.nlm.nih.gov/pubmed/35197661
http://dx.doi.org/10.5455/aim.2021.29.266-269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800573/
https://www.ncbi.nlm.nih.gov/pubmed/35197661
http://dx.doi.org/10.5455/aim.2021.29.266-269

Ejemplares similares